Thrombolysis restores perfusion in COVID-19 hypoxia.
Identifieur interne : 000125 ( Main/Exploration ); précédent : 000124; suivant : 000126Thrombolysis restores perfusion in COVID-19 hypoxia.
Auteurs : Deepa J. Arachchillage [Royaume-Uni] ; Arthur Stacey [Royaume-Uni] ; Frances Akor [Royaume-Uni] ; Martin Scotz [Royaume-Uni] ; Mike Laffan [Royaume-Uni]Source :
- British journal of haematology [ 1365-2141 ] ; 2020.
Descripteurs français
- KwdFr :
- Activateur tissulaire du plasminogène (administration et posologie), Adulte d'âge moyen (MeSH), Betacoronavirus (métabolisme), Femelle (MeSH), Humains (MeSH), Hypoxie (sang), Hypoxie (traitement médicamenteux), Hypoxie (étiologie), Infections à coronavirus (complications), Infections à coronavirus (sang), Infections à coronavirus (traitement médicamenteux), Mâle (MeSH), Pandémies (MeSH), Perfusion (MeSH), Pneumopathie virale (complications), Pneumopathie virale (sang), Pneumopathie virale (traitement médicamenteux), Sujet âgé (MeSH), Traitement thrombolytique (MeSH).
- MESH :
- administration et posologie : Activateur tissulaire du plasminogène.
- métabolisme : Betacoronavirus.
- sang : Hypoxie, Infections à coronavirus, Pneumopathie virale.
- traitement médicamenteux : Hypoxie, Infections à coronavirus, Pneumopathie virale.
- étiologie : Hypoxie.
- Adulte d'âge moyen, Femelle, Humains, Mâle, Pandémies, Perfusion, Sujet âgé, Traitement thrombolytique.
English descriptors
- KwdEn :
- Aged (MeSH), Betacoronavirus (metabolism), Coronavirus Infections (blood), Coronavirus Infections (complications), Coronavirus Infections (drug therapy), Female (MeSH), Humans (MeSH), Hypoxia (blood), Hypoxia (drug therapy), Hypoxia (etiology), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Perfusion (MeSH), Pneumonia, Viral (blood), Pneumonia, Viral (complications), Pneumonia, Viral (drug therapy), Thrombolytic Therapy (MeSH), Tissue Plasminogen Activator (administration & dosage).
- MESH :
- chemical , administration & dosage : Tissue Plasminogen Activator.
- blood : Coronavirus Infections, Hypoxia, Pneumonia, Viral.
- complications : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Hypoxia, Pneumonia, Viral.
- etiology : Hypoxia.
- metabolism : Betacoronavirus.
- Aged, Female, Humans, Male, Middle Aged, Pandemics, Perfusion, Thrombolytic Therapy.
DOI: 10.1111/bjh.17050
PubMed: 32735730
PubMed Central: PMC7436762
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thrombolysis restores perfusion in COVID-19 hypoxia.</title><author><name sortKey="Arachchillage, Deepa J" sort="Arachchillage, Deepa J" uniqKey="Arachchillage D" first="Deepa J" last="Arachchillage">Deepa J. Arachchillage</name><affiliation wicri:level="3"><nlm:affiliation>Department of haematology, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of haematology, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Immunology and Inflammation, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of haematology, Royal Brompton Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of haematology, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Stacey, Arthur" sort="Stacey, Arthur" uniqKey="Stacey A" first="Arthur" last="Stacey">Arthur Stacey</name><affiliation wicri:level="3"><nlm:affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Immunology and Inflammation, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Akor, Frances" sort="Akor, Frances" uniqKey="Akor F" first="Frances" last="Akor">Frances Akor</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pharmacology, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Pharmacology, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Scotz, Martin" sort="Scotz, Martin" uniqKey="Scotz M" first="Martin" last="Scotz">Martin Scotz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Laffan, Mike" sort="Laffan, Mike" uniqKey="Laffan M" first="Mike" last="Laffan">Mike Laffan</name><affiliation wicri:level="3"><nlm:affiliation>Department of haematology, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of haematology, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Immunology and Inflammation, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32735730</idno><idno type="pmid">32735730</idno><idno type="doi">10.1111/bjh.17050</idno><idno type="pmc">PMC7436762</idno><idno type="wicri:Area/Main/Corpus">000892</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000892</idno><idno type="wicri:Area/Main/Curation">000892</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000892</idno><idno type="wicri:Area/Main/Exploration">000892</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Thrombolysis restores perfusion in COVID-19 hypoxia.</title><author><name sortKey="Arachchillage, Deepa J" sort="Arachchillage, Deepa J" uniqKey="Arachchillage D" first="Deepa J" last="Arachchillage">Deepa J. Arachchillage</name><affiliation wicri:level="3"><nlm:affiliation>Department of haematology, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of haematology, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Immunology and Inflammation, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of haematology, Royal Brompton Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of haematology, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Stacey, Arthur" sort="Stacey, Arthur" uniqKey="Stacey A" first="Arthur" last="Stacey">Arthur Stacey</name><affiliation wicri:level="3"><nlm:affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Immunology and Inflammation, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Akor, Frances" sort="Akor, Frances" uniqKey="Akor F" first="Frances" last="Akor">Frances Akor</name><affiliation wicri:level="3"><nlm:affiliation>Department of Pharmacology, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Pharmacology, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Scotz, Martin" sort="Scotz, Martin" uniqKey="Scotz M" first="Martin" last="Scotz">Martin Scotz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Laffan, Mike" sort="Laffan, Mike" uniqKey="Laffan M" first="Mike" last="Laffan">Mike Laffan</name><affiliation wicri:level="3"><nlm:affiliation>Department of haematology, Imperial College Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of haematology, Imperial College Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Immunology and Inflammation, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">British journal of haematology</title><idno type="eISSN">1365-2141</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Betacoronavirus (metabolism)</term><term>Coronavirus Infections (blood)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (drug therapy)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Hypoxia (blood)</term><term>Hypoxia (drug therapy)</term><term>Hypoxia (etiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Perfusion (MeSH)</term><term>Pneumonia, Viral (blood)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (drug therapy)</term><term>Thrombolytic Therapy (MeSH)</term><term>Tissue Plasminogen Activator (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Activateur tissulaire du plasminogène (administration et posologie)</term><term>Adulte d'âge moyen (MeSH)</term><term>Betacoronavirus (métabolisme)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Hypoxie (sang)</term><term>Hypoxie (traitement médicamenteux)</term><term>Hypoxie (étiologie)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (sang)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Mâle (MeSH)</term><term>Pandémies (MeSH)</term><term>Perfusion (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (sang)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Sujet âgé (MeSH)</term><term>Traitement thrombolytique (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Tissue Plasminogen Activator</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Activateur tissulaire du plasminogène</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Coronavirus Infections</term><term>Hypoxia</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Hypoxia</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hypoxia</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Hypoxie</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hypoxie</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hypoxie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Perfusion</term><term>Thrombolytic Therapy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Pandémies</term><term>Perfusion</term><term>Sujet âgé</term><term>Traitement thrombolytique</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32735730</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2141</ISSN><JournalIssue CitedMedium="Internet"><Volume>190</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>09</Month></PubDate></JournalIssue><Title>British journal of haematology</Title><ISOAbbreviation>Br J Haematol</ISOAbbreviation></Journal><ArticleTitle>Thrombolysis restores perfusion in COVID-19 hypoxia.</ArticleTitle><Pagination><MedlinePgn>e270-e274</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bjh.17050</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arachchillage</LastName><ForeName>Deepa J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0001-5993-4850</Identifier><AffiliationInfo><Affiliation>Department of haematology, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of haematology, Royal Brompton Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stacey</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akor</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotz</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laffan</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8268-3268</Identifier><AffiliationInfo><Affiliation>Department of haematology, Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Inflammation, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Haematol</MedlineTA><NlmUniqueID>0372544</NlmUniqueID><ISSNLinking>0007-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.68</RegistryNumber><NameOfSubstance UI="D010959">Tissue Plasminogen Activator</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="Y">Thrombolytic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010959" MajorTopicYN="N">Tissue Plasminogen Activator</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bleeding</Keyword><Keyword MajorTopicYN="Y">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="Y">hypoxia</Keyword><Keyword MajorTopicYN="Y">thrombolysis</Keyword><Keyword MajorTopicYN="Y">tissue plasminogen activator</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32735730</ArticleId><ArticleId IdType="doi">10.1111/bjh.17050</ArticleId><ArticleId IdType="pmc">PMC7436762</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120-8.</Citation></Reference><Reference><Citation>Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233.</Citation></Reference><Reference><Citation>clinicaltrials.gov NCT04357730 [.</Citation></Reference><Reference><Citation>Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020;18(7):1752-5.</Citation></Reference><Reference><Citation>Villar J, Blanco J, del Campo R, Andaluz-Ojeda D, Díaz-Domínguez FJ, Muriel A, et al. Assessment of PaO₂/FiO₂ for stratification of patients with moderate and severe acute respiratory distress syndrome. BMJ Open. 2015;5(3):e006812.</Citation></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9.</Citation></Reference><Reference><Citation>Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging and hematologic observations. Am J Respir Crit Care Med. 2020. https://doi.org/10.1164/rccm.202004-1412OC.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Arachchillage, Deepa J" sort="Arachchillage, Deepa J" uniqKey="Arachchillage D" first="Deepa J" last="Arachchillage">Deepa J. Arachchillage</name></region><name sortKey="Akor, Frances" sort="Akor, Frances" uniqKey="Akor F" first="Frances" last="Akor">Frances Akor</name><name sortKey="Arachchillage, Deepa J" sort="Arachchillage, Deepa J" uniqKey="Arachchillage D" first="Deepa J" last="Arachchillage">Deepa J. Arachchillage</name><name sortKey="Arachchillage, Deepa J" sort="Arachchillage, Deepa J" uniqKey="Arachchillage D" first="Deepa J" last="Arachchillage">Deepa J. Arachchillage</name><name sortKey="Laffan, Mike" sort="Laffan, Mike" uniqKey="Laffan M" first="Mike" last="Laffan">Mike Laffan</name><name sortKey="Laffan, Mike" sort="Laffan, Mike" uniqKey="Laffan M" first="Mike" last="Laffan">Mike Laffan</name><name sortKey="Scotz, Martin" sort="Scotz, Martin" uniqKey="Scotz M" first="Martin" last="Scotz">Martin Scotz</name><name sortKey="Stacey, Arthur" sort="Stacey, Arthur" uniqKey="Stacey A" first="Arthur" last="Stacey">Arthur Stacey</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000125 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000125 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32735730
|texte= Thrombolysis restores perfusion in COVID-19 hypoxia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32735730" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |